spacer
spacer

PDBsum entry 2ypl

Go to PDB code: 
protein Protein-protein interface(s) links
Immune system/viral protein PDB id
2ypl

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
274 a.a.
99 a.a.
11 a.a.
199 a.a.
238 a.a.
Waters ×195
PDB id:
2ypl
Name: Immune system/viral protein
Title: Structural features underlying t-cell receptor sensitivity to concealed mhc class i micropolymorphisms
Structure: Hla class i histocompatibility antigen, b-57 alpha chain. Chain: a. Fragment: residues 25-298. Synonym: bw-57, mhc class i antigen b 57, Hla-b5703. Engineered: yes. Beta-2-microglobulin. Chain: b. Synonym: beta-2-microglobulin form pi 5.3. Engineered: yes.
Source: Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562. Synthetic: yes. Human immunodeficiency virus. Organism_taxid: 12721.
Resolution:
2.40Å     R-factor:   0.224     R-free:   0.277
Authors: G.B.Stewart-Jones,P.Simpson,P.A.Van Der Merwe,P.Easterbrook, A.J.Mcmichael,S.L.Rowland-Jones,E.Y.Jones,G.M.Gillespie
Key ref: G.B.Stewart-Jones et al. (2012). Structural features underlying T-cell receptor sensitivity to concealed MHC class I micropolymorphisms. Proc Natl Acad Sci U S A, 109, E3483. PubMed id: 23161907
Date:
30-Oct-12     Release date:   28-Nov-12    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P01889  (1B07_HUMAN) -  HLA class I histocompatibility antigen, B alpha chain from Homo sapiens
Seq:
Struc:
362 a.a.
274 a.a.*
Protein chain
Pfam   ArchSchema ?
P61769  (B2MG_HUMAN) -  Beta-2-microglobulin from Homo sapiens
Seq:
Struc:
119 a.a.
99 a.a.
Protein chain
Pfam   ArchSchema ?
Q70XD7  (Q70XD7_HV1) -  Gag polyprotein from Human immunodeficiency virus type 1
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1499 a.a.
11 a.a.
Protein chain
No UniProt id for this chain
Struc: 199 a.a.
Protein chain
No UniProt id for this chain
Struc: 238 a.a.
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 28 residue positions (black crosses)

 Enzyme reactions 
   Enzyme class 2: Chain C: E.C.3.1.13.2  - exoribonuclease H.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Exonucleolytic cleavage to 5'-phosphomonoester oligonucleotides in both 5'- to 3'- and 3'- to 5'-directions.
   Enzyme class 3: Chain C: E.C.3.1.26.13  - retroviral ribonuclease H.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.

 

 
Proc Natl Acad Sci U S A 109:E3483 (2012)
PubMed id: 23161907  
 
 
Structural features underlying T-cell receptor sensitivity to concealed MHC class I micropolymorphisms.
G.B.Stewart-Jones, P.Simpson, P.A.van der Merwe, P.Easterbrook, A.J.McMichael, S.L.Rowland-Jones, E.Y.Jones, G.M.Gillespie.
 
  ABSTRACT  
 
Polymorphic differences distinguishing MHC class I subtypes often permit the presentation of shared epitopes in conformationally identical formats but can affect T-cell repertoire selection, differentially impacting autoimmune susceptibilities and viral clearance in vivo. The molecular mechanisms underlying this effect are not well understood. We performed structural, thermodynamic, and functional analyses of a conserved T-cell receptor (TCR) which is frequently expanded in response to a HIV-1 epitope when presented by HLA-B*5701 but is not selected by HLA-B*5703, which differs from HLA-B*5701 by two concealed polymorphisms. Our findings illustrate that although both HLA-B*57 subtypes display the epitope in structurally conserved formats, the impact of their polymorphic differences occurs directly as a consequence of TCR ligation, primarily because of peptide adjustments required for TCR binding, which involves the interplay of polymorphic residues and water molecules. These minor differences culminate in subtype-specific differential TCR-binding kinetics and cellular function. Our data demonstrate a potential mechanism whereby the most subtle MHC class I micropolymorphisms can influence TCR use and highlight their implications for disease outcomes.
 

 

spacer

spacer